Values
Our identity
Consumer protection
Employees & partners
Mission
Environment
Code of conduct
Whistleblowing
Corporate compliance
Policy for the
Prevention of Corruption
Sustainability report
Benefit Company - B Corp
Kip for social
Corporate
Innovative PMI
Nutraceuticals
Profile and organization
Research and development
Company validations
Product certifications
and Declarations
Patents
Trademarks
KIP Academy
Quality & protection
Raw materials choice
Attention to food intolerances
Study about the packs
Information in braille
Tamper Evident system
Conservation and transportation
The nutraceutic module
Products
All products
Neurological Line
Kymax
®
Declinex
®
Uro-Gynecological Line
KIPFeR
®
Almetax
®
Almetax Easy
®
Ivuxur
®
sachets
Ivuxur
®
tablets
Miledix
®
Xinprox
®
Osteoarticular line
Dolatrox
®
Milesax
®
Xinepa
®
Xinepa Easy
®
Doltendix
®
Immunological Line
KIP
®
IMMUNO
Other products
Dolatrox hcc
®
Media
News
Press review
Press kit
Contact Media Relations
Contact
For consumers
For doctors
For pharmacies and health stores
For distributors
For other subjects
Work with us
Where we are
Legal notice
Privacy
E-commerce
Language
Italiano
English
Dolatrox
hcc
®
This page contains confidential content
reserved for healthcare professionals.
To proceed you need to authenticate.
LOGIN
or
Register here
Reserved Area Access
Enter your login credentials
password recovery
Related news
06/03/2023
Kolinpharma
®
for gender equity a PMIHeroes
Rita Paola Petrelli was being a guest on the podcast PMIHeroes in Ifis Bank
25/10/2022
KOLINPHARMA
®
signs an agreement with ASTAREAL
®
AB for distribution in the Asian market
An important three-year agreement for distribution of products in Mainland China...
10/03/2020
KOLINPHARMA
®
obtains the patent in the U.S. of Dolatrox
®
It is the fourth patent that is added to Ivuxur
®
and to the 2 of Xin...
08/01/2018
Tamper evident: ever-changing patented technology
The company adopted a packaging closure, which is usable even for blind people.
Language
